Alvimopan (ADL 8-2698) Is a Novel Peripheral Opioid Antagonist
- 30 November 2001
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 182 (5) , S27-S38
- https://doi.org/10.1016/s0002-9610(01)00784-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study ☆Pain, 1999
- Effect of the opioid antagonist ly 246736 on gastro-intestinal transit in human subjectsGastroenterology, 1998
- Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?International Journal of Cardiology, 1997
- Insights into opioid action in the intestinal tractPharmacology & Therapeutics, 1996
- Effects of Perioperative Analgesic Technique on Rate of Recovery after Colon SurgeryAnesthesiology, 1995
- Assessment of nalmefene glucuronide as a selective gut opioid antagonistDrug and Alcohol Dependence, 1995
- Discovery of a Potent, Peripherally Selective trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonist for the Treatment of Gastrointestinal Motility DisordersJournal of Medicinal Chemistry, 1994
- Continuous epidural infusion of bupivacaine and morphine for postoperative analgesia after hysterectomyActa Anaesthesiologica Scandinavica, 1991
- The effect of bupivacaine and morphine on pain and bowel function after colonic surgeryActa Anaesthesiologica Scandinavica, 1987
- The Central and Peripheral Influences of Opioids on Gastrointestinal PropulsionAnnual Review of Pharmacology and Toxicology, 1985